Publications by authors named "Matteo Maria Naldini"
Background: Nausea and vomiting are common side effects of Trastuzumab Deruxtecan (T-DXd), but guidelines for optimal management were not initially available. This retrospective single-center study aimed at evaluating the efficacy of two antiemetic regimens in patients receiving T-DXd.
Methods: Data from metastatic breast cancer patients receiving T-DXd were collected.
In physiological conditions, few circulating hematopoietic stem/progenitor cells (cHSPCs) are present in the peripheral blood, but their contribution to human hematopoiesis remain unsolved. By integrating advanced immunophenotyping, single-cell transcriptional and functional profiling, and integration site (IS) clonal tracking, we unveiled the biological properties and the transcriptional features of human cHSPC subpopulations in relationship to their bone marrow (BM) counterpart. We found that cHSPCs reduced in cell count over aging and are enriched for primitive, lymphoid, and erythroid subpopulations, showing preactivated transcriptional and functional state.
View Article and Find Full Text PDFIn the immunoncology era, growing evidence has shown a clear sex dimorphism in antitumor immune response with a potential impact on outcomes upon immunecheckpoint blockade (ICI) in patients with cancer. Sex dimorphism could affect tumor microenvironment composition and systemic anticancer immunity; however, the modifications induced by sex are heterogeneous. From a clinical perspective, six metanalyses have explored the role of sex in cancer patients receiving ICI with conflicting results.
View Article and Find Full Text PDFArticle Synopsis
- Base and prime editors (BEs and PEs) offer a more precise method of genetic engineering compared to traditional nuclease-based techniques, as they avoid creating DNA double-strand breaks.
- A study examined the effects of BEs and PEs on human hematopoietic stem and progenitor cells, revealing that these editors can lead to harmful transcriptional responses and lower editing efficiency while still causing some genotoxic effects, albeit less frequently than Cas9.
- The findings suggest that while BEs and PEs show potential for genetic engineering, they may pose genotoxicity risks and impact the mutational landscape of cells, highlighting the need for further research before clinical applications.
Complete elimination of B-cell acute lymphoblastic leukemia (B-ALL) by a risk-adapted primary treatment approach remains a clinical key objective, which fails in up to a third of patients. Recent evidence has implicated subpopulations of B-ALL cells with stem-like features in disease persistence. We hypothesized that microRNA-126, a core regulator of hematopoietic and leukemic stem cells, may resolve intratumor heterogeneity in B-ALL and uncover therapy-resistant subpopulations.
View Article and Find Full Text PDFImmune checkpoint inhibitors (ICIs) have revolutionized cancer therapy and now represent the mainstay of treatment for many tumor types, including triple-negative breast cancer and two agnostic registrations. However, despite impressive durable responses suggestive of an even curative potential in some cases, most patients receiving ICIs do not derive a substantial benefit, highlighting the need for more precise patient selection and stratification. The identification of predictive biomarkers of response to ICIs may play a pivotal role in optimizing the therapeutic use of such compounds.
View Article and Find Full Text PDFAcute myeloid leukemia may be characterized by a fraction of leukemia stem cells (LSCs) that sustain disease propagation eventually leading to relapse. Yet, the contribution of LSCs to early therapy resistance and AML regeneration remains controversial. We prospectively identify LSCs in AML patients and xenografts by single-cell RNA sequencing coupled with functional validation by a microRNA-126 reporter enriching for LSCs.
View Article and Find Full Text PDFArticle Synopsis
- Neutrophils, a type of immune cell, were thought to be kind of rigid, but researchers found out they can actually do many different things based on the situation.
- Scientists studied neutrophils from healthy people and patients under stress to see how they change and respond to different challenges, like infections and cancer.
- Understanding how neutrophils adapt could help doctors find new ways to diagnose and treat diseases better.
Objective: Gastrointestinal (GI) bleeding commonly requires intensive care unit (ICU) in cases of potentialhaemodynamiccompromise or likely urgent intervention. However, manypatientsadmitted to the ICU stop bleeding and do not require further intervention, including blood transfusion. The present work proposes an artificial intelligence (AI) solution for the prediction of rebleeding in patients with GI bleeding admitted to ICU.
View Article and Find Full Text PDF